The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1240
July 31, 2006
View Complete Issue         Table of Contents 2019 
Naltrexone (Vivitrol) - A Once Monthly Injection for Alcoholism
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Naltrexone (Vivitrol) - A Once Monthly Injection for Alcoholism
July 31, 2006 (Issue: 1240)
An injectable extended-release formulation of the opioid-receptor antagonist naltrexone (Vivitrol - Alkermes/Cephalon) has been approved by the FDA for once-monthly use, along with psychosocial support, to maintain abstinence from alcohol. Naltrexone...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Naltrexone (Vivitrol) - A Once Monthly Injection for Alcoholism
Article code: 1240c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.